³í¹®½ÇÀû

Áö¿ø°úÁ¦º° :
¿¬µµº° :
¸ðµÎº¸±â
Effects of testosterone and 17¥â-oestradiol on expression of the G protein-coupled receptor P2Y12 in megakaryocytic DAMI cells.(BMRC, PRCDM)
Platelets. 23(8):579-85 / 2012.12 [LINK]
2012-International
Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition.()
PLoS ONE. 7(5):e36637 / 2012.05 [LINK]
2012-International
Inter-individual variability in OCT1 expression and its relationship with OCT1 genotype in liver samples from a Korean population.(BMRC, ¼ö¼Ûü)
Drug Metab Pharmacokinet. 27(5):530-5 / 2012.11 [LINK]
2012-International
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer.(PRCDM)
Br J Cancer. 106(10):1591-7 / 2012.05 [LINK]
2012-International
Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5.(BMRC)
Xenobiotica. 42(3):278-84 / 2012.03 [LINK]
2012-International
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy.(BMRC)
Thromb Haemost. 107(2):232-40 / 2012.02 [LINK]
2012-International
The disposition of three phosphodiesterase type 5 inhibitors, vardenafil, sildenafil, and udenafil, is differently influenced by the CYP3A5 genotype.(BMRC)
Pharmacogenet Genomics. 21(12):820-8 / 2011.12 [LINK]
2011-International
Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry.(BMRC)
J Pharm Biomed Anal. 56(4):771-7 / 2011.12 [LINK]
2011-International
Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment.(BMRC)
J Korean Med Sci. 26(8):1007-13 / 2011.08 [LINK]
2011-International
Enantioselective carbonyl reduction of eperisone in human liver microsomes.(BMRC)
Xenobiotica. 41(9):758-63 / 2011.09 [LINK]
2011-International